This report contains market size and forecasts of Angiopoietin 2 in global, including the following market information:
Global Angiopoietin 2 Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Angiopoietin 2 Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Angiopoietin 2 companies in 2020 (%)
The global Angiopoietin 2 market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Angiopoietin 2 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angiopoietin 2 Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Angiopoietin 2 Market Segment Percentages, By Type, 2020 (%)
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others
Global Angiopoietin 2 Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Angiopoietin 2 Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Others
Global Angiopoietin 2 Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Angiopoietin 2 Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Angiopoietin 2 revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Angiopoietin 2 revenues share in global market, 2020 (%)
Key companies Angiopoietin 2 sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Angiopoietin 2 sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Angiopoietin 2 Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Angiopoietin 2 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Angiopoietin 2 Overall Market Size
2.1 Global Angiopoietin 2 Market Size: 2021 VS 2027
2.2 Global Angiopoietin 2 Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Angiopoietin 2 Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Angiopoietin 2 Players in Global Market
3.2 Top Global Angiopoietin 2 Companies Ranked by Revenue
3.3 Global Angiopoietin 2 Revenue by Companies
3.4 Global Angiopoietin 2 Sales by Companies
3.5 Global Angiopoietin 2 Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Angiopoietin 2 Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Angiopoietin 2 Product Type
3.8 Tier 1, Tier 2 and Tier 3 Angiopoietin 2 Players in Global Market
3.8.1 List of Global Tier 1 Angiopoietin 2 Companies
3.8.2 List of Global Tier 2 and Tier 3 Angiopoietin 2 Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Angiopoietin 2 Market Size Markets, 2021 & 2027
4.1.2 Atu-111
4.1.3 BI-836880
4.1.4 LY-3127804
4.1.5 MEDI-3617
4.1.6 Others
4.2 By Type - Global Angiopoietin 2 Revenue & Forecasts
4.2.1 By Type - Global Angiopoietin 2 Revenue, 2016-2021
4.2.2 By Type - Global Angiopoietin 2 Revenue, 2022-2027
4.2.3 By Type - Global Angiopoietin 2 Revenue Market Share, 2016-2027
4.3 By Type - Global Angiopoietin 2 Sales & Forecasts
4.3.1 By Type - Global Angiopoietin 2 Sales, 2016-2021
4.3.2 By Type - Global Angiopoietin 2 Sales, 2022-2027
4.3.3 By Type - Global Angiopoietin 2 Sales Market Share, 2016-2027
4.4 By Type - Global Angiopoietin 2 Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Angiopoietin 2 Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Angiopoietin 2 Revenue & Forecasts
5.2.1 By Application - Global Angiopoietin 2 Revenue, 2016-2021
5.2.2 By Application - Global Angiopoietin 2 Revenue, 2022-2027
5.2.3 By Application - Global Angiopoietin 2 Revenue Market Share, 2016-2027
5.3 By Application - Global Angiopoietin 2 Sales & Forecasts
5.3.1 By Application - Global Angiopoietin 2 Sales, 2016-2021
5.3.2 By Application - Global Angiopoietin 2 Sales, 2022-2027
5.3.3 By Application - Global Angiopoietin 2 Sales Market Share, 2016-2027
5.4 By Application - Global Angiopoietin 2 Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Angiopoietin 2 Market Size, 2021 & 2027
6.2 By Region - Global Angiopoietin 2 Revenue & Forecasts
6.2.1 By Region - Global Angiopoietin 2 Revenue, 2016-2021
6.2.2 By Region - Global Angiopoietin 2 Revenue, 2022-2027
6.2.3 By Region - Global Angiopoietin 2 Revenue Market Share, 2016-2027
6.3 By Region - Global Angiopoietin 2 Sales & Forecasts
6.3.1 By Region - Global Angiopoietin 2 Sales, 2016-2021
6.3.2 By Region - Global Angiopoietin 2 Sales, 2022-2027
6.3.3 By Region - Global Angiopoietin 2 Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Angiopoietin 2 Revenue, 2016-2027
6.4.2 By Country - North America Angiopoietin 2 Sales, 2016-2027
6.4.3 US Angiopoietin 2 Market Size, 2016-2027
6.4.4 Canada Angiopoietin 2 Market Size, 2016-2027
6.4.5 Mexico Angiopoietin 2 Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Angiopoietin 2 Revenue, 2016-2027
6.5.2 By Country - Europe Angiopoietin 2 Sales, 2016-2027
6.5.3 Germany Angiopoietin 2 Market Size, 2016-2027
6.5.4 France Angiopoietin 2 Market Size, 2016-2027
6.5.5 U.K. Angiopoietin 2 Market Size, 2016-2027
6.5.6 Italy Angiopoietin 2 Market Size, 2016-2027
6.5.7 Russia Angiopoietin 2 Market Size, 2016-2027
6.5.8 Nordic Countries Angiopoietin 2 Market Size, 2016-2027
6.5.9 Benelux Angiopoietin 2 Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Angiopoietin 2 Revenue, 2016-2027
6.6.2 By Region - Asia Angiopoietin 2 Sales, 2016-2027
6.6.3 China Angiopoietin 2 Market Size, 2016-2027
6.6.4 Japan Angiopoietin 2 Market Size, 2016-2027
6.6.5 South Korea Angiopoietin 2 Market Size, 2016-2027
6.6.6 Southeast Asia Angiopoietin 2 Market Size, 2016-2027
6.6.7 India Angiopoietin 2 Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Angiopoietin 2 Revenue, 2016-2027
6.7.2 By Country - South America Angiopoietin 2 Sales, 2016-2027
6.7.3 Brazil Angiopoietin 2 Market Size, 2016-2027
6.7.4 Argentina Angiopoietin 2 Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Angiopoietin 2 Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Angiopoietin 2 Sales, 2016-2027
6.8.3 Turkey Angiopoietin 2 Market Size, 2016-2027
6.8.4 Israel Angiopoietin 2 Market Size, 2016-2027
6.8.5 Saudi Arabia Angiopoietin 2 Market Size, 2016-2027
6.8.6 UAE Angiopoietin 2 Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Amgen Inc.
7.1.1 Amgen Inc. Corporate Summary
7.1.2 Amgen Inc. Business Overview
7.1.3 Amgen Inc. Angiopoietin 2 Major Product Offerings
7.1.4 Amgen Inc. Angiopoietin 2 Sales and Revenue in Global (2016-2021)
7.1.5 Amgen Inc. Key News
7.2 AnGes MG, Inc.
7.2.1 AnGes MG, Inc. Corporate Summary
7.2.2 AnGes MG, Inc. Business Overview
7.2.3 AnGes MG, Inc. Angiopoietin 2 Major Product Offerings
7.2.4 AnGes MG, Inc. Angiopoietin 2 Sales and Revenue in Global (2016-2021)
7.2.5 AnGes MG, Inc. Key News
7.3 Boehringer Ingelheim GmbH
7.3.1 Boehringer Ingelheim GmbH Corporate Summary
7.3.2 Boehringer Ingelheim GmbH Business Overview
7.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Major Product Offerings
7.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Sales and Revenue in Global (2016-2021)
7.3.5 Boehringer Ingelheim GmbH Key News
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Corporate Summary
7.4.2 Eli Lilly and Company Business Overview
7.4.3 Eli Lilly and Company Angiopoietin 2 Major Product Offerings
7.4.4 Eli Lilly and Company Angiopoietin 2 Sales and Revenue in Global (2016-2021)
7.4.5 Eli Lilly and Company Key News
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales and Revenue in Global (2016-2021)
7.5.5 F. Hoffmann-La Roche Ltd. Key News
7.6 MedImmune, LLC
7.6.1 MedImmune, LLC Corporate Summary
7.6.2 MedImmune, LLC Business Overview
7.6.3 MedImmune, LLC Angiopoietin 2 Major Product Offerings
7.6.4 MedImmune, LLC Angiopoietin 2 Sales and Revenue in Global (2016-2021)
7.6.5 MedImmune, LLC Key News
7.7 Regeneron Pharmaceuticals, Inc.
7.7.1 Regeneron Pharmaceuticals, Inc. Corporate Summary
7.7.2 Regeneron Pharmaceuticals, Inc. Business Overview
7.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Major Product Offerings
7.4.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales and Revenue in Global (2016-2021)
7.7.5 Regeneron Pharmaceuticals, Inc. Key News
7.8 RXi Pharmaceuticals Corporation
7.8.1 RXi Pharmaceuticals Corporation Corporate Summary
7.8.2 RXi Pharmaceuticals Corporation Business Overview
7.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Major Product Offerings
7.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales and Revenue in Global (2016-2021)
7.8.5 RXi Pharmaceuticals Corporation Key News
7.9 Silence Therapeutics Plc
7.9.1 Silence Therapeutics Plc Corporate Summary
7.9.2 Silence Therapeutics Plc Business Overview
7.9.3 Silence Therapeutics Plc Angiopoietin 2 Major Product Offerings
7.9.4 Silence Therapeutics Plc Angiopoietin 2 Sales and Revenue in Global (2016-2021)
7.9.5 Silence Therapeutics Plc Key News
7.10 Synergys Biotherapeutics, Inc.
7.10.1 Synergys Biotherapeutics, Inc. Corporate Summary
7.10.2 Synergys Biotherapeutics, Inc. Business Overview
7.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Major Product Offerings
7.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales and Revenue in Global (2016-2021)
7.10.5 Synergys Biotherapeutics, Inc. Key News
8 Global Angiopoietin 2 Production Capacity, Analysis
8.1 Global Angiopoietin 2 Production Capacity, 2016-2027
8.2 Angiopoietin 2 Production Capacity of Key Manufacturers in Global Market
8.3 Global Angiopoietin 2 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Angiopoietin 2 Supply Chain Analysis
10.1 Angiopoietin 2 Industry Value Chain
10.2 Angiopoietin 2 Upstream Market
10.3 Angiopoietin 2 Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Angiopoietin 2 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Angiopoietin 2 in Global Market
Table 2. Top Angiopoietin 2 Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Angiopoietin 2 Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Angiopoietin 2 Revenue Share by Companies, 2016-2021
Table 5. Global Angiopoietin 2 Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Angiopoietin 2 Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Angiopoietin 2 Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Angiopoietin 2 Product Type
Table 9. List of Global Tier 1 Angiopoietin 2 Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Angiopoietin 2 Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.